GraphIX: Graph-based In silico XAI(explainable artificial intelligence) for drug repositioning from biopharmaceutical network

GraphIX demonstrates that AI models can learn to distinguish between different types of biological entities (diseases, drugs, proteins) without being explicitly told which is which, suggesting that explainable AI systems can discover meaningful patterns in complex biological networks on their own.

The framework identifies specific protein nodes as key to understanding why a drug might work for a new disease, providing a concrete mechanism for researchers to validate AI predictions through follow-up biological studies rather than treating the model as a "black box."

This work addresses a critical gap in drug repositioning: while AI can predict which drugs might treat new diseases faster and cheaper than traditional methods, the model's reasoning must be transparent and scientifically grounded for doctors and researchers to trust and act on these predictions.

The paper emphasizes that explainability in drug repositioning isn't just about transparency—it's essential for safety and efficacy, since confirming that a repurposed drug actually affects the right biological targets is necessary before applying it to new diseases in real patients.

By quantitatively evaluating whether the AI's explanations are actually valid (rather than just plausible-sounding), GraphIX contributes to settling ongoing debates about whether explainable AI methods truly reveal how models make decisions or merely provide convincing narratives.